Display: A A A Contact  | Links
Enabling Clinical and Translational Research

Programmes


IPCOR

The Irish Prostate Cancer Outcomes Research (IPCOR) Project is a clinically-led study that aims to improve the treatment and care of men diagnosed with prostate cancer in Ireland thus maximising their quality of life. 

IPCOR was started in 2014 with funding from the Irish Cancer Society and Movember. It will establish the first register for the purpose of monitoring, benchmarking and publicly reporting the outcomes of prostate cancer care.

More>>

 
 -----------------------------------------------------------------------------
                            

 iPROSPECT

The Irish PROgramme for Stratified ProstatE Cancer Therapy (iPROSPECT) was established in 2014 with funding from the Irish Cancer Society in partnership with Movember. 

The aim of iPROSPECT is to develop and implement informed patient stratification, based on greater understanding of the intra- and inter-cellular signalling pathways driving disease progression, and deliver a programme of stratified oncology for patients with prostate cancer.

More>>

------------------------------------------------------------------------------- 

Prostate Cancer Research Consortium

Created in October 2003, with funding from the Irish Cancer Society, the Prostate Cancer Research Consortium is a multi-disciplinary, trans-institutional collaboration bringing together researchers from UCD, TCD, RCSI and DCU along with five teaching hospitals in a combined effort to identify novel disease biomarkers for earlier detection and more reliable prognosis for prostate cancer. The federated bioresource of the PCRC has collected tissue, serum/plasma, urine and DNA from 450 patients and these bio-resources fuel the current discovery and validation research programme.

More >>

--------------------------------------------------------------------------------


Irish Cervical Screening Research Consortium (CERVIVA)

The CERVIVA consortium, funded by the Health Research Board, is a multi-investigator collaboration encompassing researchers at seven Irish universities, eight hospitals and ten commercial diagnostic/ biotechnology companies. CERVIVA aims to instigate and advance high quality peer-reviewed research programmes that provide the best possible information and guidance in the delivery of cervical screening services to women living in Ireland. This research is significant considering that approximately 85 Irish women die each year from cervical cancer which is almost twice the EU average.

More >>

-------------------------------------------------------------------------------